Day: October 5, 2021
WESTPORT, Conn., Oct. 05, 2021 (GLOBE NEWSWIRE) — Compass Diversified (NYSE: CODI) (“CODI” or the Company”), an owner of leading middle market businesses, announced today that its Board of Directors (the “Board”) has declared a quarterly cash distribution of $0.36 per share on the Company’s common shares (the “Common Shares”). The distribution for the three months ended September 30, 2021 is payable on October 22, 2021 to all holders of record of Common Shares as of October 15, 2021.
“Following our transition to be treated as a corporation and simplifying our tax structure last month, we are excited to mark the first time CODI will pay common and preferred cash distributions, which to the extent of earnings and profits, will be qualified dividends,” said Elias Sabo, CEO of CODI. “With a significantly lower cost of capital and a...
Keweenaw Land Announces Acquisition Of 29,071 Acres Of Mineral Properties In Michigan And Wisconsin
Written by Customer Service on . Posted in Mergers And Acquisitions.
IRONWOOD, Mich., Oct. 05, 2021 (GLOBE NEWSWIRE) — Keweenaw Land Association, Limited (OTC US: KEWL) announced today that it has completed the purchase of 29,071 acres of severed mineral properties from Sage Minerals Inc. for $5,000,000 in cash.
The primary driver for the purchase was to increase Keweenaw’s ownership of the mineral reserves underlying Highland Copper’s Copperwood Project. The transaction includes 2,500 acres of mineral rights adjacent to our existing interests and increases Keweenaw’s mineral tenure to around 80% of Copperwood’s overall estimated reserves. The newly acquired acreage is already under a lease and option agreement with Highland Copper Company that has been assumed by Keweenaw and will convert to a royalty once the Copperwood Project goes into production.
The mineral package Keweenaw acquired also contained...
Saratoga Investment Corp. Announces Fiscal Second Quarter 2022 Financial Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
NEW YORK, Oct. 05, 2021 (GLOBE NEWSWIRE) — Saratoga Investment Corp. (NYSE:SAR) (“Saratoga Investment” or “the Company”), a business development company (“BDC”), today announced financial results for its 2022 fiscal second quarter.
Summary Financial Information
The Company’s summarized financial information is as follows:
For the quarterended and as ofAug 31, 2021
For the quarterended and as ofMay 31, 2021
For the quarterended and as ofAug 31, 2020
($ in thousands except per share)AUM
666,097
677,773
508,117
NAV
324,112
320,345
298,177
NAV per share
28.97
28.70
26.68
Investment Income
18,442
16,816
13,856
Net Investment Income per share
0.57
0.23
0.48
Adjusted Net Investment Income per share
0.63
0.56
0.49
Earnings per share
0.71
1.88
1.95
Dividends per share (declared)
0.52
0.44
0.41
Return...
Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.
Written by Customer Service on . Posted in Mergers And Acquisitions.
DUBLIN, Ireland and TREVOSE, Pa., Oct. 05, 2021 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc (NASDAQ: SBBP) (the “Company” or “Strongbridge”) today announced that the High Court of Ireland (the “Court”) has approved the previously announced proposed acquisition of Strongbridge by Xeris Pharmaceuticals, Inc. (Nasdaq: XERS) (“Xeris”) by means of a scheme of arrangement (the “Scheme”) under Chapter 1 of Part 9 of the Irish Companies Act 2014 (the “Act”).
The Court sanction hearing in relation to the Scheme was held earlier today at which the Court sanctioned the Scheme and confirmed the related reduction of capital.
The Scheme became effective earlier today on October 5, 2021 upon the registration of the following documents by the Registrar of Companies in Ireland:The order of the Court sanctioning...
UPDATE: Galectin Therapeutics to Participate in the H.C. Wainwright 5th Annual NASH Investor Conference on October 12, 2021
Written by Customer Service on . Posted in Public Companies.
NORCROSS, Ga., Oct. 05, 2021 (GLOBE NEWSWIRE) — Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, announced today the Company will be participating in the H.C. Wainwright 5th Annual NASH Investor Conference being held virtually on October 12, 2021.
Dr. Pol F. Boudes, Galectin Therapeutics’ Chief Medical Officer, will be participating in a fireside chat with H.C. Wainwright NASH analyst Ed Arce at 11:00 AM ET.
A live webcast of the discussion will be available at https://journey.ct.events/view/fa61e0d5-797c-4e8a-98e4-83c508113cc4 as well as through the investor relations section of the Company’s website at www.galectintherapeutics.com.
About Belapectin (GR-MD-02)Belapectin (GR-MD-02) is a complex carbohydrate drug that targets galectin-3, a critical protein in the pathogenesis...
Mid Penn Bank Contributes $125,000 to the Pennsylvania Breast Cancer Coalition
Written by Customer Service on . Posted in Public Companies.
Mid Penn Bank Contributes $125,000 to the Pennsylvania Breast Cancer CoalitionMid Penn Bank raised $125,000 for the Pennsylvania Breast Cancer Coalition through the sixth annual Mid Penn Bank Celebrity Golf Classic for Breast Cancer Charity. Rory Ritrievi, President and CEO of Mid Penn Bank, presents the contribution to Pat Halpin-Murphy, President and Founder of the PBCC.MILLERSBURG, Pa., Oct. 05, 2021 (GLOBE NEWSWIRE) — Mid Penn Bancorp, Inc. (NASDAQ: MPB), parent company of the wholly-owned subsidiaries Mid Penn Bank and MPB Financial Services, Inc., is pleased to announce a $125,000 donation to the Pennsylvania Breast Cancer Coalition (PBCC) through the sixth annual Mid Penn Bank Celebrity Golf Classic for Breast Cancer Charity.
The three-day Classic hosted 190 golfers and more than 50 celebrities. The events...
extractX Ltd. Announces Completion of Business Acquisition of extractX Incorporated
Written by Customer Service on . Posted in Mergers And Acquisitions.
NIAGARA, Ontario, Oct. 05, 2021 (GLOBE NEWSWIRE) — extractX Ltd. (formerly Tri-Media Integrated Marketing Technologies Inc.) (the “Company“), is pleased to announce that it completed its previously communicated business acquisition of extractX Incorporated (“EXI”) by its wholly owned subsidiary, 12491613 Canada Inc. on October 1, 2021 and the subsequent amalgamation of EXI and 12491613 Canada Inc. The Articles of Amalgamation naming the new entity, extractX Incorporated (“new EXI”) will be filed upon receipt from Corporations Canada.
The consideration given by 12491613 Canada Inc. for the acquisition was an exchange of one Company common share for one common share outstanding of EXI. As stated in the Amalgamation Agreement at June 30, 2021, EXI had 23,352,287 common shares outstanding and the Company had 937,533 common...
Brookfield Infrastructure Partners to Host Third Quarter 2021 Results Conference Call
Written by Customer Service on . Posted in Public Companies.
Wednesday, November 3, 2021 at 9:00 a.m. (ET)
BROOKFIELD, NEWS, Oct. 05, 2021 (GLOBE NEWSWIRE) — Brookfield Infrastructure Partners will hold its third quarter 2021 conference call and webcast on Wednesday, November 3, 2021 at 9:00 a.m. ET.
Results will be released on November 3, 2021 at approximately 7:00 a.m. ET and will also be available following the release on our website at https://bip.brookfield.com/bip.
To participate in the conference call, please dial +1-866-688-9459 toll-free in North America, or for overseas calls please dial +1-409-216-0834 at approximately 8:50 a.m. (Conference ID: 6329445). The conference call will be webcast live at https://edge.media-server.com/mmc/p/xa7d38tg and will be archived for future reference.
For those unable to participate in the Conference Call, a rebroadcast will also be available...
Proactive news headlines including Thesis Gold, IEC Electronics, Tetra Bio-Pharma and Mydecine
Written by Customer Service on . Posted in Mergers And Acquisitions.
New York, Oct. 05, 2021 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:Tetra Bio-Pharma (TSX:TBP, OTCQB:TBPMF) says its first cannabinoid-derived medicine REDUVO is a ‘major milestone’ as it gears up to launch it click here
DeepSpatial partners with international development consulting group to provide its Geospatial AI solutions click here
Enveric Biosciences (NASDAQ:ENVB) uses AI platform to identify potential molecules for further drug discovery click here
Thesis Gold releases ‘outstanding’ assays from ongoing drill at the Ranch gold and copper project click here
Phunware announces Ten Million PhunToken Sweepstakes in conjunction with a new release of PhunWallet on Apple iOS and Google Android click here
Talon...
Automotive Blockchain Market worth USD 5.68 billion by 2030, registering a CAGR of 33.56% – Report by Market Research Future (MRFR)
Written by Customer Service on . Posted in Mergers And Acquisitions.
New York, Oct. 05, 2021 (GLOBE NEWSWIRE) — Automotive Blockchain Market Overview: According to a comprehensive research report by Market Research Future (MRFR), “Automotive Blockchain Market Research Report, Technology, Application, Vehicle type, End Market and Region – Forecast till 2030” the market is projected to be worth USD 5.68 billion by 2030, registering a CAGR of 33.56% during the forecast period (2021 – 2030)., The market was valued at USD 0.65 billion in 2021.
Key Players
List of the Notable players in the global automotive blockchain market profiled are –IBM Corporation (US)
Microsoft Corporation (US)
BigchainDB GmbH (Germany)
carVertical (Estonia)
Helbiz (US)
ShiftMobility (US)
RSK Labs (Argentina)
Tech Mahindra (India)
HCL Technologies (India)
XAIN (Germany).Get Free Sample PDF Brochure
https://www.marketresearchfuture.com/sample_request/7735...